Stabilium & Chronic Fatigue
The Positive Role of a Nutraceutic
in Memory and Cognitive Functions
and Symptoms of Chronic Fatigue in Adults
Le Poncin M., Pallier E., Elbaz H.
April 27, 2000
A nutraceutical fish protein extract, Garum Armoricum
("GA"), which we previously studied for weakness and fatigue-related depression
and anxiety, has recently been tested in a crossover, double blind versus
placebo study to examine it's effects in memory and cognitive disorders.
Results show statistically significant positive effects, especially in the
40-50 years of age group. It seems that GA, through its favorable effect on
weakness and fatigue-related depression, helps to improve memory and cognitive
function as well.
A reduction in memory and intellectual capacities is
affecting men and women at an increasingly early age. In an attempt to provide
a natural solution to the challenges caused by the stress of modem living (one
of which is the gradual loss of memory and cognitive function), is the aim of
this study. In this study, GA was tested versus placebo. Its performance was
measured in terms of GA's modifying effects on mind and behavior, and GA's
effects on memory and cognitive performance.
Significant Differences Among Age
Groups
Sleep: The refreshing |effects of sleep leveled
out over the various age groups.
Motivation: There was a distinct improvement in
motivation and drive, particularly in subjects 56 and older.
Concentration: There was a noticeable
improvement in the ability to concentrate (an essential faculty in memory
processes) in subjects 56 and older.
Immediate Memorization: All age groups
demonstrated an improvement in immediate memorization, as demonstrated by
Wechsler's Test of Memorization, and Rey's Test (memorization of 15 words),
which showed an improvement in subjects between age 45 and 55.
Memorization of Things Learned: The positive
effects on learning ability were particularly apparent in the 45-55 age group.
Summary of Statistically Significant
Results
This study clearly demonstrates that GA may be
beneficial to a variety of age groups experiencing difficulties with memory and
mental clarity. The GA therapy was shown to be statistically superior to the
placebo. Those with symptoms of greatest severity (age 56 and over) appeared to
benefit the most. Significant improvement in cognitive function and motivation
occurred. In the age group 45-55, there was a clear improvement in performance
in terms of immediate memorization, learning, and capacity for differential
memorization (Rey).
As we have demonstrated both in human and animal
studies, GA is currently well established as a treatment for weakness and
chronic fatigue, as well as anxiety. It may be that in alleviating this
syndrome, GA potentiates the cognitive functions of memorization and learning.
Conclusion
Garum Armoricum, a natural substance, integrated in
human nutrition for many centuries, is rich in essential fatty acids and
micropeptides. The composition of this substance is original and controlled,
and has been subjected to thorough, high quality testing. All studies have
confirmed that GA has no harmful side effects and is not addictive. It has
demonstrated efficacy throughout this double-blind trial versus placebo.
In a 2-3 month course of treatment, beginning with an
aggressive dose of 2 capsules in the morning and 2 capsules in the evening for
1 month; followed by 1 capsule in the morning and 1 capsule in the evening for
an additional 2 months, GA facilitates the regaining of effective memory and
cognitive function, while relieving symptoms of weakness, chronic fatigue, and
anxiety. It is well known that these psychological and cognitive functions are
interrelated, which was clearly demonstrated by the symptoms reported by the
subjects included in this study.
References:
- Le Poncin M. Experimental Study: Stress and Memory.
The Journal of the European College of Neuropsychopharmacology 6(3):110, 1996.
- Dorman T, et al. The Effectiveness of Stabilium on
Reducing Anxiety in College Students. Journal of Advance in Medicine
83:193-200, 1995.
- Le Poncin M Psychopathology Due to Sedentary Life:
in Sedentary Life and Nutrition. Medical and Social Aspect Aging Series, Turin
Raven Press, 1990.
- Elbaz M. Astheno - Depression. Cahiers de
Biotherapie, No. 100, December 3. 1988.
- Poitrenaud J. Les Modifications au Cours du
Veillissement Cerebral Normal. Investigations Cliniques ot Para Cliniques dans
le Veillissement Cerebral. Doin, Paris, pp. 17-34.
- Hamon M La Transmission de L'influx Nerveux Role
des Nuro Transmetteurs. Gaz Med de France 89(30): 3539-3555, 1982.
- Studler JM. Tassin JP. Les Neuro Transmitters. Gaz
Med de France, 89(30):3539-3555, 1982.
- Botwinick J. Intellectual Abilities. Birren J.E.
and Schiee K.W. Handbook of the Psychology of Aging, New York, 1977.
Clinical Results of the Effect of
Stabilium on 40 Chronic Fatigue Patients
Crocq L, Bugard P, et al.
The aim of this study was to determine the therapeutic
effectiveness of Stabilium 200 on 40 patients who had been suffering from
weakness and/or chronic fatigue for a period of 1 to 3 months. Four capsules of
Stabilium 200 were administered for 15 days and the results recorded on Day O
and Day 15. The results demonstrated the benefits Of Stabilium 200 reflected in
statistically significant improvements in chronic fatigue/weakness-related
symptoms and categories.
The following table summarizes the results of the
study.
Clinical Trial Demonstrates
Improvement for Chronic Fatigue-Related Symptoms |
